Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study

“Working Group” of Systemic Autoinflammatory Diseases of SIR (Italian Society of Rheumatology)

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study'. Together they form a unique fingerprint.

Medicine & Life Sciences